Co-Authors
This is a "connection" page, showing publications co-authored by Bernd Salzberger and Matthias Lubnow.
Connection Strength
0.754
-
ECMO in COVID-19-prolonged therapy needed? A retrospective analysis of outcome and prognostic factors. Perfusion. 2021 09; 36(6):582-591.
Score: 0.233
-
Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppression. Int J Infect Dis. 2021 Feb; 103:624-627.
Score: 0.231
-
Contribution of High Viral Loads, Detection of Viral Antigen and Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity. J Infect Dis. 2022 01 18; 225(2):190-198.
Score: 0.062
-
Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes. Nat Commun. 2021 05 21; 12(1):3006.
Score: 0.059
-
Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Virchows Arch. 2021 Jul; 479(1):97-108.
Score: 0.058
-
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization. Infection. 2021 Feb; 49(1):75-82.
Score: 0.056
-
Coronavirus disease 2019 induces multi-lineage, morphologic changes in peripheral blood cells. EJHaem. 2020 Jun 29.
Score: 0.056